GlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds, majority owned by the British company.
GSK said on Wednesday the deal laid the foundation for the creation of two new UK-based global companies focused on Pharmaceuticals/Vaccines and Consumer Healthcare.
from Top News & Analysis https://ift.tt/2Cl7XKr
No comments:
Post a Comment